← Back to headlines
Merck Stock Price Prediction Reaches $150 on Sac-TMT Drug Potential
Analysts predict Merck's stock (MRK) could reach $150, driven by the potential of its Sac-TMT drug.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
